China Medical System Holdings Limited (HKG:0867)
Hong Kong · Delayed Price · Currency is HKD 10.35
-0.30 (-2.82%)
Jun 8, 2026, 4:09 PM HKT
HKG:0867 Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, HKG:0867 stock has a consensus rating of "Strong Buy" and an average price target of $17.85. The average 1-year stock price forecast is 72.46% higher than the current stock price, while the lowest is $15.44 (+49.18%) and the highest is $19.85 (+91.79%).
Price Target: $17.85 (+72.46%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 29, 2026.
Analyst Ratings
The average analyst rating for HKG:0867 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 7 | 6 | 7 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 9 | 8 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Guotai Haitong No rating | Guotai Haitong | Buy Maintains $18.63 → $19.05 | Buy | Maintains | $18.63 → $19.05 | +84.06% | Apr 29, 2026 |
Unknown Analyst First Shanghai Securities No rating | First Shanghai Securities | Buy Maintains $19.30 | Buy | Maintains | $19.30 | +86.47% | Mar 20, 2026 |
Unknown Analyst CICC No rating | CICC | Buy Maintains $16.50 → $17.50 | Buy | Maintains | $16.50 → $17.50 | +69.08% | Mar 19, 2026 |
Unknown Analyst Guoyuan Securities (HK) No rating | Guoyuan Securities (HK) | Buy Maintains $17.68 | Buy | Maintains | $17.68 | +70.82% | Dec 18, 2025 |
Unknown Analyst TFI Asset Management No rating | TFI Asset Management | Buy Maintains $17.85 | Buy | Maintains | $17.85 | +72.46% | Dec 1, 2025 |
Financial Forecast
Revenue This Year
9.86B
from 8.21B
Increased by 20.07%
Revenue Next Year
11.63B
from 9.86B
Increased by 17.98%
EPS This Year
0.84
from 0.73
Increased by 13.79%
EPS Next Year
1.04
from 0.84
Increased by 24.55%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 10.0B | ||
| Avg | 9.9B | ||
| Low | 9.7B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 22.1% | ||
| Avg | 20.1% | ||
| Low | 17.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.87 | ||
| Avg | 0.84 | ||
| Low | 0.80 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 18.6% | ||
| Avg | 13.8% | ||
| Low | 9.0% |